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Major studies targeting aging are exploring whether the antidiabetic drug metformin can extend the health span (and maybe even lifespan) in people without diabetes, based on findings from worms and mice. [2] [3] [4] [5] Justice et al. 6 explore if the effects of metformin are due to changes in biomarkers (interlukin-6, tumor necrosis factor alpha-receptor I or II, C-reactive protein, GDF15, insulin, insulin-like growth factor 1, cystatin C, N-terminal pro b-type natriuretic peptide, and hemoglobin A1c). 6 Lest you act prematurely and convince your doctor to prescribe metformin before the results are known, metformin can blunt exercise capacity. 7 Another potential intervention proposed to extend the health span is nicotinamide riboside and pterostil-bene. 8, 9 Although this combination targets energy metabolism and has been shown to extend the lifespan of worms and mice, no data have shown similar results in humans. One study has shown, however, that the combination increases nicotinamide adenine dinucleotide blood levels in humans. 10 Despite the paucity of evidence, the combination is being sold as a supplement that targets longevity gene activation.
And what about our patients? Why do they die prematurely? One clue may be that, for example, patients with bipolar disorder have shorter telomeres than healthy controls. 11 Another clue may be the overlap between genes for psychiatric and cardiovascular risk. 12 Our patients also have challenges with regulating their diet, exercise, and sleep, resulting in metabolic problems compounded by the medications that they are taking.
Advances in increasing the health span may change the way we and our patients live, but we still have a long way to go.
